The official site of «SAM Pharmaceuticals Ltd»
Research & Development
On September 14th and 15th, 2018, the 3rd All-Russian Scientifc and Practical Conference with international participation "Innovations in the Diagnosis and Treatment of Cardiovascular Diseases"...
13-15 September 2018 in Yaroslavl will host the XXXIV internatonal onferen e “Prospe ts of development of vas ular surgery in Russia and its regions”
September 11th, 2018 St. Petersburg. The Second St. Petersburg practical course “Applied aspects of vascular surgery, interventional radiology and phlebology. A difcult case in my practice1
Subscribe to news
Representation of companies in Russia
Parliament of the Russian Federation considered in the first reading amendments to the federal budget for 2015. Health budget is expected to sequester 25.1% (34.7 billion rubles).
Russian Prime Minister Dmitry Medvedev has called for a shift in Russian manufacturing 90-95% of vital and essential drugs (VED).
Scientists of St.Petersburg have developed a prototype experimental model of a portable device that allows to restore blood circulation.
Incidence of tuberculosis decreased by 20% and mortality decreased by 50% in the Russian Federation for the last 8 years. These significant changes related to the introduction of federal programs for socially significant diseases.
The Ministry of Economic Development, the Ministry of Finance and the Ministry of Industry has proposed to introduce new rules of long-term government contracts. It will allow customers to buy goods directly from the manufacturer - without competition. Long-term contracts (up to 7 years) will be based on the agreements on the localization of production. If the entrepreneur develops the production of Russian products, the state will buy its products without bidding as a single supplier. This should encourage suppliers to create a Russian production.
© 2018, SAM Pharmaceuticals